Background: Hospital administrative data have been suggested as a valuable cost-effective tool for providing information about the stroke burden. Nevertheless, the choice of the diagnosis codes has been a critical issue in the development of case ascertainment algorithms. Methods: In this study, the Minimum Basic Data Set administrative database was used to analyze the accuracy of different ICD-9-CM algorithms based on the neurologist's clinical judgement as the ‘gold standard'. Results: The most accurate algorithm observed in our study involved the selection of ICD-9-CM codes 430-438 in the primary diagnosis. It yielded a sensitivity of 96.1%, a specificity of 87.5% and a positive predictive value of 82.5%. Conclusions: The Minimum Basic Data Set is a valuable source to evaluate stroke frequency when using an accurate algorithm to select events.

1.
Marrugat J, Arboix A, García-Eroles L, Salas T, Vila J, Castell C, Tresserras R, Elosua R: Estimación de la incidencia poblacional y la mortalidad de la enfermedad cerebrovascular establecida isquémica y hemorrágica en 2002. Rev Esp Cardiol 2007;60:573-280.
2.
Heuschmann PU, Di Carlo A, Bejot Y, Rastenyte D, Ryglewicz D, Sarti C, Torrent M, Wolfe CD: Incidence of stroke in Europe at the beginning of the 21st century. Stroke 2009;40:1557-1563.
3.
Vega T, Zurriaga O, Ramos JM, Gil M, Alamo R, Lozano JE, Lopez A, Miralles MT, Vaca P, Alvarez MM: Stroke in Spain: epidemiologic incidence and patterns; a health sentinel network study. J Stroke Cerebrovasc Dis 2009;18:11-16.
4.
Medrano MJ, Boix R, Cerrato E, Ramírez M: Incidencia y prevalencia de cardiopatía isquémica y enfermedad cerebrovascular en España: revisión sistemática de la literatura. Rev Esp Salud Pública 2006;80:5-15.
5.
Derby CA, Lapane KL, Feldman HA, Carleton RA: Trends in validated cases of fatal and nonfatal stroke, stroke classification, and risk factors in southeastern New England, 1980 to 1991: data from the Pawtucket Heart Health Program. Stroke 2000;31:875-881.
6.
Moore DF, Lix LM, Yogendran MS, Martens P, Tamayo A: Stroke surveillance in Manitoba, Canada: estimates from administrative databases. Chronic Dis Can 2008;29:22-30.
7.
Ellekjaer H, Holmen J, Kruger O, Terent A: Identification of incident stroke in Norway: hospital discharge data compared with a population-based stroke register. Stroke 1999;30:56-60.
8.
Goldstein LB: Accuracy of ICD-9-CM coding for the identification of patients with acute ischemic stroke: effect of modifier codes. Stroke 1998;29:1602-1604.
9.
Johansen HL, Wielgosz AT, Nguyen K, Fry RN: Incidence, comorbidity, case fatality and readmission of hospitalized stroke patients in Canada. Can J Cardiol 2006;22:65-71.
10.
Kokotailo RA, Hill MD: Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10. Stroke 2005;36:1776-1781.
11.
Leibson CL, Naessens JM, Brown RD, Whisnant JP: Accuracy of hospital discharge abstracts for identifying stroke. Stroke 1994;25:2348-2355.
12.
Piriyawat P, Smajsova M, Smith MA, Pallegar S, Al-Wabil A, Garcia NM, Risser JM, Moye LA, Morgenstern LB: Comparison of active and passive surveillance for cerebrovascular disease: the Brain Attack Surveillance in Corpus Christi (BASIC) Project. Am J Epidemiol 2002;156:1062-1069.
13.
Reker DM, Hamilton BB, Duncan PW, Yeh SC, Rosen A: Stroke: who's counting what? J Rehabil Res Dev 2001;38:281-289.
14.
Spolaore P, Brocco S, Fedeli U, Visentin C, Schievano E, Avossa F, Milan G, Toso V, Vanuzzo D, Pilotto L, Pessina AC, Bonita R: Measuring accuracy of discharge diagnoses for a region-wide surveillance of hospitalized strokes. Stroke 2005;36:1031-1034.
15.
Tirschwell DL, Longstreth WT Jr: Validating administrative data in stroke research. Stroke 2002;33:2465-2470.
16.
Roumie CL, Mitchel E, Gideon PS, Varas-Lorenzo C, Castellsague J, Griffin MR: Validation of ICD-9 codes with a high positive predictive value for incident strokes resulting in hospitalization using Medicaid health data. Pharmacoepidemiol Drug Saf 2008;17:20-26.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.